CD274 and atherosclerosis: Additionally, a series of clinical and in vitro studies suggest that therapeutic effects of statins on atherosclerosis (214–219) and rapamycin on cardiac transplant rejection (220) may be through altering endothelial expression of PD-L1 and CD40.